James Hippel - Aug 15, 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
CFO
Signature
/s/ Brenda S. Furlow, Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed
Stock symbol
TECH
Transactions as of
Aug 15, 2022
Transactions value $
$0
Form type
4
Date filed
8/17/2022, 05:20 PM
Previous filing
Aug 9, 2022
Next filing
Aug 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TECH Common Stock 12.8K Aug 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Award $0 +2.73K $0.00 2.73K Aug 15, 2022 Common Stock 2.73K Direct F1, F2
transaction TECH Stock Options (Right to Buy) Award $0 +8.48K $0.00 8.48K Aug 15, 2022 Common Stock 8.48K $378.08 Direct F2
transaction TECH Stock Options (Right to Buy) Award $0 +11.3K $0.00 11.3K Aug 15, 2022 Common Stock 11.3K $378.08 Direct F3
holding TECH Stock Options (Right to Buy) 47.4K Aug 15, 2022 Common Stock 47.4K $125.05 Direct F4
holding TECH Stock Options (Right to Buy) 18.1K Aug 15, 2022 Common Stock 18.1K $177.32 Direct F4
holding TECH Stock Options (Right to Buy) 24.1K Aug 15, 2022 Common Stock 24.1K $177.32 Direct F4
holding TECH Stock Options (Right to Buy) 19.9K Aug 15, 2022 Common Stock 19.9K $190.41 Direct F5
holding TECH Stock Options (Right to Buy) 26.6K Aug 15, 2022 Common Stock 26.6K $190.41 Direct F6
holding TECH Stock Options (Right to Buy) 14.4K Aug 15, 2022 Common Stock 14.4K $267.87 Direct F7
holding TECH Stock Options (Right to Buy) 19.1K Aug 15, 2022 Common Stock 19.1K $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 8.33K Aug 15, 2022 Common Stock 8.33K $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 8.33K Aug 15, 2022 Common Stock 8.33K $267.87 Direct F10
holding TECH Restricted Stock Units 1.95K Aug 15, 2022 Common Stock 1.95K Direct F1, F11
holding TECH Stock Options (Right to Buy) 7.6K Aug 15, 2022 Common Stock 7.6K $481.82 Direct F11
holding TECH Stock Options (Right to Buy) 10.1K Aug 15, 2022 Common Stock 10.1K $481.82 Direct F12
holding TECH Restricted Stock Units 3.22K Aug 15, 2022 Common Stock 3.22K Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F2 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3 Options to purchase 2,826 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026 and options to purchase 2,827 shares vest on 8/15/2024.
F4 Fully exercisable.
F5 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later ate as performance is certified by the Administrator).
F6 Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/22 and 8/7/2023.
F7 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Option to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024.
F9 Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F10 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F11 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12 Options to purchase 2,534 shares vests on each of 8/6/2022 and 8/6/2023 and options to purchase 2,533 shares vests on each of 8/6/2024 and 8/6/2025.